Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 28, 2022
[Dual Immunotherapy in Advanced Non-small Cell Lung Cancer: 
the Progress and Clinical Application]Haiyi Deng, Liqiang Wang, Yilin Yang, et al.
Experimental and Therapeutic Medicine|May 1, 2023
Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case reportJiaxi Deng, Xinqing Lin, Haiyi Deng, et al.
Immunopharmacology and Immunotoxicology|June 20, 2023
A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse eventXinqing Lin, Wenhui Guan, Bingliang Li, et al.
Chinese Medical Journal|October 15, 2024
Cancer therapy-related interstitial lung diseaseChengzhi Zhou, Haiyi Deng, Yilin Yang, et al.
Heliyon|February 5, 2024
Coexistence of a novel SRBD1-ALK, ALK-CACNA1D double-fusion in a lung adenocarcinoma patient and response to alectinib: A case reportXiaohong Xie, Wenhui Guan, Wenting Huang, et al.
Frontiers in Oncology|October 7, 2021
Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKIHaiyi Deng, Xinqing Lin, Xiaohong Xie, et al.
Frontiers in Immunology|June 21, 2021
Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 TherapyXinqing Lin, Guihuan Qiu, Fang Li, et al.
Cell Death & Disease|January 6, 2025
Anti-PD-1 exacerbates bleomycin-induced lung injury in mice via Caspase-3/GSDME-mediated pyroptosisFei Wang, Haiyi Deng, Maolin Zhou, et al.
Frontiers in Oncology|December 6, 2021
Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With <i>EGFR</i> Germline Mutations in a Large-Scale Retrospective StudyXinqing Lin, Muyun Peng, Quanfang Chen, et al.
Frontiers in Immunology|January 31, 2022
Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor PneumonitisXinqing Lin, Jiaxi Deng, Haiyi Deng, et al.
Pageof 4